Published: Guidance, quality standards and advice
Showing 1 to 3 of 3
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer | TA389 | ||
| Topotecan for the treatment of relapsed small-cell lung cancer | TA184 | ||
| Topotecan for the treatment of recurrent and stage IVB cervical cancer | TA183 |